Synaptogenix Inc (SNPX)

[Cyosol]

That is true. Admitting you are wrong is a notoriously difficult thing for most people to do, not to mention huge pharmaceutical companies that have poured billions of dollars and decades of work into the wrong approach.

Being the first to get on board NTRP can however offset that embarrassment IMO, considering the consequences will be even worse if those companies spent all that effort on the wrong approach and then miss this train on top of that.

I think a successful confirmatory trial on our side, and a few more failed trials on their side should help get things going in the right direction.